Inventor
SILVIA BUONAMICI
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides16%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms16%
C07DHeterocyclic compounds13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
PatentTitleYear
12,514,926Splicing modulator antibody-drug conjugates and methods of use202612,172,986Splicing modulator antibody-drug conjugates and methods of use202411,998,544Methods of using splicing modulators202411,945,807Splicing modulator antibody-drug conjugates and methods of use202411,761,045Splice variants associated with neomorphic SF3B1 mutants202311,524,009Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use202211,352,348Splicing modulator antibody-drug conjugates and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to EISAI R&D MAN CO LTD (7)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EISAI R&D MAN CO LTD | 7 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |